Arkolith/Insider Trading/COEP/Form 4

Mehalick David

CEO and President, Director, 10% OwnerCoeptis Therapeutics Inc. (COEP) · full profile →Form 4 · filed Nov 18, 2021
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 16, 2021Sell(S)1.2M——1.8M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001683168-21-005808) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML